share_log

Goldman Sachs Maintains Neutral on Cue Health, Lowers Price Target to $0.75

Benzinga ·  Jun 5, 2023 08:08

Goldman Sachs analyst Matthew Sykes maintains Cue Health (NASDAQ:HLTH) with a Neutral and lowers the price target from $2.75 to $0.75.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment